146 related articles for article (PubMed ID: 32800281)
1. Corrigendum to "The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center" [Eur. J. Surg. Oncol. 46/3 (2019) 402-409].
Asoglu O; Tokmak H; Bakir B; Demir G; Ozyar E; Atalar B; Goksel S; Koza B; Mert AG; Demir A; Guven K
Eur J Surg Oncol; 2020 Sep; 46(9):1774. PubMed ID: 32800281
[No Abstract] [Full Text] [Related]
2. Corrigendum to " Clinical impact of splenic hilar dissection with splenectomy for gastric stump cancer " [Eur J Surg Oncol 45/8 (2019) 1505-1510].
Watanabe M; Kinoshita T; Morita S; Yura M; Tokunaga M; Otsuki S; Yamagata Y; Kaito A; Yoshikawa T; Katai H
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1971. PubMed ID: 32826111
[No Abstract] [Full Text] [Related]
3. Corrigendum to "A ctDNA-driven multidisciplinary treatment strategy for resectable colorectal cancer -what surgical oncologists should know" [Eur. J. Surg. Oncol. 48(1) (2022) 1-2].
Kataoka K; Yamada T; Taniguchi H; Ikeda M; Yamazaki K; Kanemitsu Y
Eur J Surg Oncol; 2023 Jul; 49(7):1327. PubMed ID: 37002177
[No Abstract] [Full Text] [Related]
4. Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer.
Sharma R; Beith J; Hamilton A
Breast; 2005 Jun; 14(3):181-91. PubMed ID: 15927827
[TBL] [Abstract][Full Text] [Related]
5. Erratum to "Management of the positive pathologic circumferential resection margin in rectal cancer: A national cancer database (NCDB) study" [Eur J Surg Oncol 47 (2) (February 2021) 296-303].
Reif de Paula T; Augestad KM; Kiran RP; Keller DS
Eur J Surg Oncol; 2023 Oct; 49(10):106949. PubMed ID: 37620244
[No Abstract] [Full Text] [Related]
6. Corrigendum to 'Soft tissue sarcoma of the hand: Is unplanned excision a problem? [Eur J Surg Oncol 45/7 (2019) 1281-1287].
Lans J; Yue KC; Castelein RM; Chen NC; Lozano-Calderon SA
Eur J Surg Oncol; 2021 May; 47(5):1232. PubMed ID: 33678518
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
Di Micco R; Zuber V; Fiacco E; Carriero F; Gattuso MI; Nazzaro L; Panizza P; Gianolli L; Canevari C; Di Muzio N; Pasetti M; Sassi I; Zambetti M; Gentilini OD
Eur J Surg Oncol; 2019 Sep; 45(9):1754. PubMed ID: 31307816
[No Abstract] [Full Text] [Related]
8. Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937].
Bundred NJ
Eur J Surg Oncol; 2018 Jan; 44(1):194. PubMed ID: 29174199
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671].
Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C
Eur J Surg Oncol; 2017 Jul; 43(7):1380-1381. PubMed ID: 28526188
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma" [Eur J Surg Oncol 46 2 (2019) 263-271].
Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
Eur J Surg Oncol; 2020 May; 46(5):928. PubMed ID: 32165000
[No Abstract] [Full Text] [Related]
11. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "Staging of oropharyngeal squamous cell carcinoma of the head and neck: Prognostic features and power of the 8th edition of the UICC staging manual" [Eur. J. Surg. Oncol. 45 (6) (2019) 1046-1053].
Beltz A; Gösswein D; Zimmer S; Limburg I; Wünsch D; Gribko A; Deichelbohrer M; Hagemann J; Stauber RH; Künzel J
Eur J Surg Oncol; 2019 Sep; 45(9):1755-1756. PubMed ID: 31307815
[No Abstract] [Full Text] [Related]
13. Corrigendum to "European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO" [Eur J Surg Oncol 50 (1) (January 2024) 107292].
Rubio IT; Wyld L; Marotti L; Athanasiou A; Regitnig P; Catanuto G; Schoones JW; Zambon M; Camps J; Santini D; Dietz J; Sardanelli F; Varga Z; Smidt M; Sharma N; Shaaban AM; Gilbert F
Eur J Surg Oncol; 2024 Mar; 50(3):107943. PubMed ID: 38246851
[No Abstract] [Full Text] [Related]
14. Total mesopancreas excision in pancreatic head adenocarcinoma: The same impact as total mesorectal excision in rectal carcinoma? Comment on article "surgical technique and results of total mesopancreas excision in pancreatic tumours" by Adham M and Singhirunnusorn J, Eur J Surg Oncol, 2012.
Dumitrascu T; Popescu I
Eur J Surg Oncol; 2012 Aug; 38(8):725; author reply 726. PubMed ID: 22525857
[No Abstract] [Full Text] [Related]
15. Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues.
De Felice F; Musio D; Izzo L; Tombolini V
World J Gastrointest Oncol; 2014 Dec; 6(12):438-40. PubMed ID: 25516776
[TBL] [Abstract][Full Text] [Related]
16. Retraction notice to "Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trials" [Eur J Surg Oncol 40 (10) (October 2014) 1321-1330].
Eur J Surg Oncol; 2015 Jul; 41(7):953. PubMed ID: 26266275
[No Abstract] [Full Text] [Related]
17. Zang RY, Zhang ZY, Li ZT et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Eur J Surg Oncol 2000; 26:798-804.
Sugarbaker PH
Eur J Surg Oncol; 2001 Aug; 27(5):515-6. PubMed ID: 11504529
[No Abstract] [Full Text] [Related]
18. Neoadjuvant treatment for rectal cancer-A value-based proposition.
Massarweh NN; Artinyan A; Chang GJ
J Surg Oncol; 2016 Sep; 114(3):304-10. PubMed ID: 27111410
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neo-adjuvant therapy for curable rectal cancer--reaching a consensus 2008.
Scott NA; Susnerwala S; Gollins S; Myint AS; Levine E
Colorectal Dis; 2009 Mar; 11(3):245-8. PubMed ID: 18637934
[TBL] [Abstract][Full Text] [Related]
20. The impact of body mass index and nuclear β-catenin on survival in locally advanced rectal cancer treated with preoperative radiochemotherapy.
Gomez-Millan J; Queipo MI; Del Mar Delgado M; Perez-Villa L; Roman A; De la Portilla F; Torres E; De Luque V; Bayo E; Medina JA
J Surg Oncol; 2017 Mar; 115(3):301-306. PubMed ID: 28335081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
